1,002
Views
58
CrossRef citations to date
0
Altmetric
Brief Report

Management of Chinese patients with type 2 diabetes, 1998–2006: the Diabcare-China surveys

, , , &
Pages 39-45 | Accepted 29 Oct 2008, Published online: 21 Nov 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Xiaocen Kong, Menghui Luo, Ling Cai, Peng Zhang, Rengna Yan, Yun Hu, Huiqin Li & Jianhua Ma. (2021) Needle-free jet injection of insulin glargine improves glycemic control in patients with type 2 diabetes mellitus: a study based on the flash glucose monitoring system. Expert Opinion on Drug Delivery 18:5, pages 635-641.
Read now
Yixuan Sun, Jian Wang, Huiqin Li, Xiaojuan Sun, Xiaofei Su & Jianhua Ma. (2020) Comparison of glucose variability in patients with type 2 diabetes administrated glargine with needle-free jet injector and conventional insulin pen. Expert Opinion on Drug Delivery 17:5, pages 713-717.
Read now
Xiaoning He, Liming Chen, Ke Wang, Haiya Wu & Jing Wu. (2017) Insulin adherence and persistence among Chinese patients with type 2 diabetes: a retrospective database analysis. Patient Preference and Adherence 11, pages 237-245.
Read now
Glen Y. Ozawa, Marcus A. Bearse$suffix/text()$suffix/text() & Anthony J. Adams. (2015) Male–Female Differences in Diabetic Retinopathy?. Current Eye Research 40:2, pages 234-246.
Read now
Jiajia Ji & Qingqing Lou. (2014) Insulin pen injection technique survey in patients with type 2 diabetes in mainland China in 2010. Current Medical Research and Opinion 30:6, pages 1087-1093.
Read now

Articles from other publishers (53)

Weimin Wang, Xin Yan, Zhifeng Cheng, Qiqi Zhang, Rui Wang, Yuying Deng, Jianhua Ma & Dalong Zhu. (2023) Efficacy and safety of adding once‐weekly dulaglutide to basal insulin for inadequately controlled type 2 diabetes in Chinese patients ( AWARD‐CHN3 ): A randomized, double‐blind, placebo‐controlled, phase III trial . Diabetes, Obesity and Metabolism 25:12, pages 3690-3699.
Crossref
Wenjing Li, Lanbo Peng, Chao Yang & Guangmin Chen. (2021) Diagnostic significance of serum PP4R1 and its predictive value for the development of chronic complications in patients with type 2 diabetes mellitus. Diabetology & Metabolic Syndrome 13:1.
Crossref
PanPan Zuo, JianFeng Shi, Juan Yan, LiHong Yang, Chao Liu, Li Yuan & QingQing Lou. (2019) Effects of Insulin Therapy and Oral Hypoglycemic Agents on Glycemic Control for Type 2 Diabetes Mellitus Patients in China–A Case Control Study. Experimental and Clinical Endocrinology & Diabetes 129:05, pages 374-378.
Crossref
Lixin Guo, Baocheng Chang, Li Chen, Liyong Yang, Yu Liu, Bo Feng & Qinghua He. (2021) Composite cardiovascular risk and BMI affected comparative profiles of BIAsp 30 + metformin vs BIAsp 30 monotherapy: a MERIT post-hoc analysis. Scientific Reports 11:1.
Crossref
Beshir Bedru Nasir, Miftah Shafi Buseir & Oumer Sada Muhammed. (2021) Knowledge, attitude and practice towards insulin self-administration and associated factors among diabetic patients at Zewditu Memorial Hospital, Ethiopia. PLOS ONE 16:2, pages e0246741.
Crossref
Kaiyong Liang, Qiao Xie, Jieping Nie & Jieqing Deng. (2021) Study on the effect of education for insulin injection in diabetic patients with new simulation tools. Medicine 100:14, pages e25424.
Crossref
Jin Yang, Qing Tian, Yuexin Tang, Arvind K. Shah, Ruya Zhang, Guojuan Chen, Ye Zhang, Swapnil Rajpathak & Tianpei Hong. (2020) Effect of Dipeptidyl Peptidase 4 Inhibitors Used in Combination with Insulin Treatment in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis. Diabetes Therapy 11:10, pages 2371-2382.
Crossref
Yun Yu, Kaipeng Xie, Qinglin Lou, Hui Xia, Dan Wu, Lingli Dai, Cuining Hu, Kunlin Wang, Shan Shan, Yun Hu & Wei Tang. (2020) The achievement of comprehensive control targets among type 2 diabetes mellitus patients of different ages. Aging 12:14, pages 14066-14079.
Crossref
Yan Wei, Yingyao Chen, Yingnan Zhao, Russell Rothman, Jian Ming, Lei Wang, Xiaona Liu, Lizheng Shi & Wanghong Xu. (2020) Health literacy and exercise interventions on clinical outcomes in Chinese patients with diabetes: a propensity score-matched comparison. BMJ Open Diabetes Research & Care 8:1, pages e001179.
Crossref
Shanshan Du, Jingzhi Shao, Ying Qi, Xuhui Liu, Jingjing Liu & Fengyan Zhang. (2020) Long non-coding RNA ANRIL alleviates H2O2-induced injury by up-regulating microRNA-21 in human lens epithelial cells. Aging 12:8, pages 6543-6557.
Crossref
Yichen Zhang, Jing Wu, Yingyao Chen & Lizheng Shi. (2020) EQ-5D-3L Decrements by Diabetes Complications and Comorbidities in China. Diabetes Therapy 11:4, pages 939-950.
Crossref
Wenhui Mao, Chi-Man Winnie Yip & Wen Chen. (2019) Complications of diabetes in China: health system and economic implications. BMC Public Health 19:1.
Crossref
Lei Wang, Hong Fang, Qinghua Xia, Xiaona Liu, Yingyao Chen, Peng Zhou, Yujie Yan, Baodong Yao, Yan Wei, Yu Jiang, Russell L. Rothman & Wanghong Xu. (2019) Health literacy and exercise-focused interventions on clinical measurements in Chinese diabetes patients: A cluster randomized controlled trial. EClinicalMedicine 17, pages 100211.
Crossref
Volker Foos, Ke Wang, Phil McEwan, Yanlei Zhang, Ping Xin, Xiaohua Jiang, Shuli Qu, Tengbin Xiong, Raf De Moor, Mafalda Ramos, Mark Lamotte & Linong Ji. (2019) Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling Approach. Value in Health Regional Issues 18, pages 36-46.
Crossref
Tianmeng Yang, Rongjiong Zheng, Qingmei Chen & Yushan Mao. (2018) Current status of treatment of type 2 diabetes mellitus in Ningbo, China. Journal of Clinical Laboratory Analysis 33:3, pages e22717.
Crossref
Lixin Guo, Li Chen, Baocheng Chang, Liyong Yang, Yu Liu & Bo Feng. (2018) A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral anti. Diabetes, Obesity and Metabolism 20:12, pages 2740-2747.
Crossref
Abdul Marouf Raoufi, Xue Tang, Zhengyue Jing, Xinyi Zhang, Qiongqiong Xu & Chengchao Zhou. (2018) Blood Glucose Monitoring and Its Determinants in Diabetic Patients: A Cross-Sectional Study in Shandong, China. Diabetes Therapy 9:5, pages 2055-2066.
Crossref
Yue Gao, Ke Wang, Yun Chen, Li Shen, Jianing Hou, Jianwei Xuan & Bao Liu. (2018) A Real-World Anti-Diabetes Medication Cost Comparison Between Premixed Insulin Analogs and Long-Acting Insulin Analogs in Chinese Patients with Type 2 Diabetes: A Retrospective Database Analysis. Diabetes Therapy 9:2, pages 673-682.
Crossref
Siddique Latif, Muhammad Yasir Khan, Adnan Qayyum, Junaid Qadir, Muhammad Usman, Syed Mustafa Ali, Qammer Hussain Abbasi & Muhammad Ali Imran. 2018. Mobile Applications and Solutions for Social Inclusion. Mobile Applications and Solutions for Social Inclusion 261 287 .
Ao Yu, David Adelson & David Mills. (2018) Chinese Herbal Medicine Versus Other Interventions in the Treatment of Type 2 Diabetes. Journal of Evidence-Based Integrative Medicine 23, pages 2515690X1878151.
Crossref
Linni Gu, Shaomin Wu, Shuliang Zhao, Huixuan Zhou, Shengfa Zhang, Min Gao, Zhiyong Qu, Weijun Zhang & Donghua Tian. (2017) Association of Social Support and Medication Adherence in Chinese Patients with Type 2 Diabetes Mellitus. International Journal of Environmental Research and Public Health 14:12, pages 1522.
Crossref
Fang-Fang Zhao, Riitta Suhonen, Sanna Koskinen & Helena Leino-Kilpi. (2017) Theory-based self-management educational interventions on patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Journal of Advanced Nursing 73:4, pages 812-833.
Crossref
Changyu Pan, Ping Han, Qiuhe Ji, Chengjiang Li, Juming Lu, Jinkui Yang, Wenhui Li, Jiaoe Zeng, An‐Tsz Hsieh & Juliana Chan. (2016) Efficacy and safety of alogliptin in patients with type 2 diabetes mellitus: A multicentre randomized double‐blind placebo‐controlled Phase 3 study in mainland China, Taiwan, and Hong Kong. Journal of Diabetes 9:4, pages 386-395.
Crossref
Shan Shan, Liubao Gu, Qinglin Lou, Xiaojun Ouyang, Yun Yu, Haidi Wu & Rongwen Bian. (2015) Evaluation of glycemic control in patients with type 2 diabetes mellitus in Chinese communities: a cross-sectional study. Clinical and Experimental Medicine 17:1, pages 79-84.
Crossref
Yanhu Dong, Weiguo Gao, Lei Zhang, Jia Wei, Niklas Hammar, Claudia S Cabrera, Xiaoli Wu & Qing Qiao. (2016) Patient characteristics related to metabolic disorders and chronic complications in type 2 diabetes mellitus patients hospitalized at the Qingdao Endocrine and Diabetes Hospital from 2006 to 2012 in China. Diabetes and Vascular Disease Research 14:1, pages 24-32.
Crossref
Zijian Li, Haimin Jin, Wei Chen, Zilin Sun, Lulu Jing, Xiaohui Zhao, Sainan Zhu, Xiaohui Guo & China NEEDs Study Group. (2017) Influencing Factors of Knowledge, Attitude, and Practice regarding Medical Nutrition Therapy in Patients with Diabetes: A National Cross-Sectional Study in Urban China. Journal of Diabetes Research 2017, pages 1-10.
Crossref
Xiaoming Tao, Jihu Li, Xiaolin Zhu, Bin Zhao, Jiao Sun, Linong Ji, Dayi Hu, Changyu Pan, Yuxin Huang, Suyuan Jiang, Qiang Feng & Cuiping Jiang. (2016) Association between socioeconomic status and metabolic control and diabetes complications: a cross-sectional nationwide study in Chinese adults with type 2 diabetes mellitus. Cardiovascular Diabetology 15:1.
Crossref
Su Yen Goh, Ernesto Ang, Shailendra Bajpai, Chaicharn Deerochanawong, Eun-Gyoung Hong, Zanariah Hussein, Shashank Joshi, Nor Azmi Kamaruddin, Sjoberg Kho, Alice Pik-Shan Kong, Chang Yu Pan, Riccardo Perfetti, Apichati Vichayanrat, Aleksandra Vlajnic & Juliana Chung-Ngor Chan. (2016) A patient-centric approach to optimise insulin therapy in Asia. Journal of Diabetes and its Complications 30:6, pages 973-980.
Crossref
Jiaxing Tian, Fengmei Lian, Xiaotong Yu, Yashan Cui, Tianyu Zhao, Yang Cao & Xiaolin Tong. (2016) The Efficacy and Safety of Chinese Herbal Decoction in Type 2 Diabetes: A 5-Year Retrospective Study. Evidence-Based Complementary and Alternative Medicine 2016, pages 1-8.
Crossref
Li Yan, Ming Tong Xu, Li Yuan, Bing Chen, Zhang Rong Xu, Qing Hua Guo, Qiang Li, Yu Duan, Jian Huang Fu, Yong Jian Wang, Miao Zhang, Zuo Jie Luo, Wei Gang Zhao, You Min Wang, Zhen Fang Yuan, Wei Qing Wang, Peng Hua Wang, Xing Wu Ran, Yan Jun Wang, Hua Zhang Yang, Ling Gao, Wei Qing Chen & Guang Ning. (2016) Prevalence of dyslipidemia and its control in type 2 diabetes: A multicenter study in endocrinology clinics of China. Journal of Clinical Lipidology 10:1, pages 150-160.
Crossref
Michael Mendoza & Colleen Loo-Gross. 2016. Men's Health in Primary Care. Men's Health in Primary Care 125 143 .
Jian-Ping Weng & Yan Bi. (2015) Epidemiological Status of Chronic Diabetic Complications in China. Chinese Medical Journal 128:24, pages 3267-3269.
Crossref
Lihua ZhangLinong JiLixin GuoJuming LuHaoming TianDalong ZhuXiaoping XingJian Ping WengWeiping Jia. (2015) Treatment Patterns and Glycemic Control in Older Adults with Type 2 Diabetes Mellitus Receiving Only Oral Antidiabetes Drugs in China. Diabetes Technology & Therapeutics 17:11, pages 816-824.
Crossref
Lin Liu, Qingqing Lou, Xiaohui Guo, Li Yuan, Li Shen, Zilin Sun, Fang Zhao, Xia Dai, Jin Huang, Huiying Yang & John P. Mordes. (2015) Management status and its predictive factors in patients with type 2 diabetes in China: A Nationwide Multicenter Study. Diabetes/Metabolism Research and Reviews 31:8, pages 811-816.
Crossref
Chao Liu, Wei Xiang, Yan Yu, Zheng-Qin Shi, Xian-Zhi Huang & Li Xu. (2015) Comparative analysis of 1-deoxynojirimycin contribution degree to α-glucosidase inhibitory activity and physiological distribution in Morus alba L. Industrial Crops and Products 70, pages 309-315.
Crossref
Jing Li, Zheng Li, Weigang Zhao, Hui Pan & Edward J. Halloran. (2014) The Reliability and Validity of the Diabetes Care Profile for Chinese Populations. Evaluation & the Health Professions 38:2, pages 200-218.
Crossref
Atsunori Kashiwagi, Noriko Akiyama, Takanori Shiga, Kenichi Kazuta, Atsushi Utsuno, Satoshi Yoshida & Eiji Ueyama. (2014) Efficacy and safety of ipragliflozin as an add-on to a sulfonylurea in Japanese patients with inadequately controlled type 2 diabetes: results of the randomized, placebo-controlled, double-blind, phase III EMIT study. Diabetology International 6:2, pages 125-138.
Crossref
Yun Chen, Li Liu, Liqun Gu, Steven Babineaux, Hayley Colclough & Bradley Curtis. (2015) Glycemic Control in Chinese Patients with Type 2 Diabetes Mellitus Receiving Oral Antihyperglycemic Medication-Only or Insulin-Only Treatment: A Cross-Sectional Survey. Diabetes Therapy 6:2, pages 197-211.
Crossref
Weiping Jia, Xinhua Xiao, Qiuhe Ji, Kyu-Jeung Ahn, Lee-Ming Chuang, Yuqian Bao, Can Pang, Lei Chen, Fei Gao, Yinfang Tu, Pengfei Li & Jun Yang. (2015) Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trial. The Lancet Diabetes & Endocrinology 3:4, pages 254-262.
Crossref
Linong Ji, Juming Lu, Jianping Weng, Weiping Jia, Haoming Tian, Dalong Zhu, Xiaoping Xing & Lixin Guo. (2015) China type 2 diabetes treatment status survey of treatment pattern of oral drugs users. Journal of Diabetes 7:2, pages 166-173.
Crossref
Satish K. Garg, Karim Admane, Nick Freemantle, Masato Odawara, Chang-Yu Pan, Anoop Misra, Iwona R. Jarek-Martynowa, Syed Abbas-Raza, Roberto C. Mirasol & Riccardo Perfetti. (2015) Patient-Led Versus Physician-Led Titration of Insulin Glargine in Patients with Uncontrolled Type 2 Diabetes: A Randomized Multinational Atlas Study. Endocrine Practice 21:2, pages 143-157.
Crossref
Roopa Shivashankar, Katy Kirk, Woon Cho Kim, Chaturia Rouse, Nikhil Tandon, K.M. Venkat Narayan & Mohammed K. Ali. (2015) Quality of diabetes care in low- and middle-income Asian and Middle Eastern countries (1993–2012) – 20-Year systematic review. Diabetes Research and Clinical Practice 107:2, pages 203-223.
Crossref
Jin-Hee JungJung-Hwa LeeJin-Won NohJeong-Eun ParkHee-Sook KimJoo-Wha YooBok-Rye SongJeong-rim LeeMyeong-Hee HongHyang-Mi JangYoung NaHyun-Joo LeeJeong-Mi LeeYang-Gyo KangSun-Young KimKang-Hee Sim. (2015) Current Status of Management in Type 2 Diabetes Mellitus at General Hospitals in South Korea. Diabetes & Metabolism Journal 39:4, pages 307.
Crossref
Wang Hong Xu, Russell L Rothman, Rui Li, Yingyao Chen, Qinghua Xia, Hong Fang, Junling Gao, Yujie Yan, Peng Zhou, Yu Jiang, Yinan Liu, Fangjia Zhou, Wei Wang, Minling Chen, Xiao Yu Liu & Xiao Na Liu. (2014) Improved self-management skills in Chinese diabetes patients through a comprehensive health literacy strategy: study protocol of a cluster randomized controlled trial. Trials 15:1.
Crossref
Linong Ji, Dayi Hu, Changyu Pan, Jianping Weng, Yong Huo, Changsheng Ma, Yiming Mu, Chuanming Hao, Qiuhe Ji, Xingwu Ran, Benli Su, Hanjing Zhuo, Keith A.A. Fox, Michael Weber & Danyi Zhang. (2013) Primacy of the 3B Approach to Control Risk Factors for Cardiovascular Disease in Type 2 Diabetes Patients. The American Journal of Medicine 126:10, pages 925.e11-925.e22.
Crossref
Yan Bi, Jinhua Yan, Weili Tang, Jing Yang & Jianping Weng. (2013) Prevalence of hypoglycemia identified by intensive bedside glucose monitoring among hospitalized patients with diabetes mellitus (住院的糖尿病患者强化床边血糖监测检出的低血糖患病率). Journal of Diabetes 5:3, pages 300-301.
Crossref
Keiko Arai, Masahiko Takai, Koichi Hirao, Ikuro Matsuba, Kiyokazu Matoba, Hiroshi Takeda, Akira Kanamori, Mikio Yamauchi, Hisao Mori & Yasuo Terauchi. (2012) Present status of insulin therapy for type 2 diabetes treated by general practitioners and diabetes specialists in Japan: Third report of a cross‐sectional survey of 15,652 patients. Journal of Diabetes Investigation 3:4, pages 396-401.
Crossref
C. Pan, W. Yang, W. Jia, J. Weng, G. Liu, B. Luo, X. Li, Z. Fu & H. Tian. (2012) Psychological status of Chinese patients with Type 2 diabetes: data review of Diabcare-China studies. Diabetic Medicine 29:4, pages 515-521.
Crossref
Wan-gen Li, Xin-lian He, Tong Zhang, Guang-da Xiang, Jian-min Ran, Cheng Peng & Hong Zhang. (2011) Hemoglobin A1c proportion, mortality rate, and risk factors for death in diabetic patients with severe hypoglycemia: A multicenter retrospective survey over ten years. Diabetes Research and Clinical Practice 93:1, pages 17-20.
Crossref
Vamadevan S. Ajay & Dorairaj Prabhakaran. (2011) The Scope of Cell Phones in Diabetes Management in Developing Country Health Care Settings. Journal of Diabetes Science and Technology 5:3, pages 778-783.
Crossref
-Wei Du Hong, -Yue Li Jia & He Yao. (2011) Glycemic and blood pressure control in older patients with hypertension and diabetes: association with carotid atherosclerosis. Journal of Geriatric Cardiology 8:1, pages 24-30.
Crossref
Wing‐Yee So & Juliana C. N. Chan. 2010. Textbook of Diabetes. Textbook of Diabetes 969 983 .
Yan Bi, Dalong Zhu, Jinluo Cheng, Yan Zhu, Ning Xu, Shiwei Cui, Wei Li, Xingbo Cheng, Fei Wang, Yun Hu, Shanmei Shen & Jianping Weng. (2010) The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the jiangsu province of China. Clinical Therapeutics 32:5, pages 973-983.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.